Augmedix, Inc. CFO Paul Ginocchio Buys 10,000 Shares
| AUGXDelisted Stock | USD 2.35 0.00 0.00% |
Slightly above 56% of Augmedix's investor base is looking to short. The analysis of current outlook of investing in Augmedix suggests that many traders are alarmed regarding Augmedix's prospects. Augmedix's investing sentiment can be driven by a variety of factors including economic data, Augmedix's earnings reports, geopolitical events, and overall market trends.
Augmedix |
Augmedix, Inc. CFO Paul Ginocchio purchased 10,000 shares of Augmedix stock in a transaction dated Wednesday, November 22nd. The stock was bought at an average cost of 4.85 per share, for a total transaction of 48,500.00. Following the completion of the purchase, the chief financial officer now directly owns 128,000
Read at thelincolnianonline.com
 |
Augmedix Fundamental Analysis
We analyze Augmedix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Augmedix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Augmedix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Augmedix is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Augmedix Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Augmedix stock to make a market-neutral strategy. Peer analysis of Augmedix could also be used in its relative valuation, which is a method of valuing Augmedix by comparing valuation metrics with similar companies.
Peers
Augmedix Related Equities
| ACON | Aclarion | 5.88 | ||||
| ELEV | Elevation Oncology | 3.23 | ||||
| DRMA | Dermata Therapeutics | 2.73 | ||||
| INAB | In8bio | 3.23 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |